Diagnostic and therapeutic challenges.
Ober
Michael D
MD
Edward S. Harkness Eye Institute, Columbia University College of Physiciams amd Surgeons, New York, NY, USA.
Del Priore
Lucian V
LV
Tsai
James
J
Lopez
Robert
R
Lobes
Louis A
LA
Puklin
James E
JE
Young
Tara
T
D000293:Adolescent; D000740:Anemia / Q000150:complications* / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077555:Methylprednisolone Acetate; D020388:Muscular Dystrophy, Duchenne / Q000150:complications*; D011994:Recombinant Proteins; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014786:Vision Disorders / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014821:Vitrectomy; D014823:Vitreous Hemorrhage / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
D000893:Anti-Inflammatory Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000077555:Methylprednisolone Acetate; D000068817:Epoetin Alfa; D008775:Methylprednisolone